Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery
نویسندگان
چکیده
منابع مشابه
Personalised Medicine
In recent years we have seen the emergence of “personalised medicine.” This development can be seen as the logical product of reductionism in medical science in which disease is increasingly understood in molecular terms. Personalised medicine has flourished as a consequence of the application of neoliberal principles to health care, whereby a commercial and social need for personalised medicin...
متن کاملOvercoming barriers to priority setting using interdisciplinary methods.
Ten years ago, Holm's highly influential paper "Goodbye to the simple solutions: the second phase of priority setting" was published [Holm S. Goodbye to the simple solutions: the second phase of priority setting in health care. British Medical Journal 1998;317:1000-7]. Whilst attending the 2nd International Conference on Priorities in Health Care in London, Holm argued that the search for a rat...
متن کاملOvercoming Barriers to Evaluation of Terminological Systems
Evaluation of terminological systems has been demonstrated to be a complicated task. This is due to the broad range of terminological systems, their application, and the clinical contexts in which they can be applied. We propose an evaluation framework that explicitly distinguishes an application-independent description of terminological systems, methods to determine application-dependent requi...
متن کاملOvercoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry
Every cancer treatment, irrespective of its clinical effectiveness, has an impact on patients' quality of life (QoL). Even recently developed targeted therapies might have side effects and significantly impact patients' QoL. Thus, understanding the advantages and disadvantages of different treatments from the patient's standpoint has become a must in clinical research and is highly valued by ma...
متن کاملOvercoming immunologic barriers to discordant organ xenotransplantation
time, reduced ischemic injury) may counterbalance the poor HLA matching in the ULD group. Although the arguments against the use of living donors must be considered, long-term prospects for kidney donors is reassuring provided there is careful evaluation of potential donors and the strict criteria for exclusion are respected [2]. The benefit for the donor must also not be ignored. Our current p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Healthcare
سال: 2019
ISSN: 2227-9032
DOI: 10.3390/healthcare7040134